Narmac .... I would love to see an IPO, especially available in the U.S. Isn't this something Cencora can help with though, for direction and guidance, connections? Still trying to figure out what all they can do for us? - strat planning, future commercialization, sale, etc? 

But what would you even offer Zenith for on the open market as far as price (IPO), that people would actually buy, given current price? ..... IIRC many of these P2's will be winding down later this year, and if they finish successfully and we have the support to move into multiple promising P3's, with continued BP funding/guidance/involvement/interest, we "could" be in a very nice bargaining spot for Zenith (or an IPO and/or Nasdaq). Maybe?

Fingers crossed that the P2's finish successfully and meet their endpoints, and that cancer portfolios remain a strong interest and focus for many in 2025, like Pfizer, etc.